Avicenna Alliance: enhanced knowledge, improved decisions, better outcomes
FULL MENU

Better outcome of vascular accesses for hemodialysis patients

Better outcome of vascular accesses for hemodialysis patients

BACK

Better outcome of vascular accesses for hemodialysis patients

Renal failure requires chronic hemodialisis treatment with extracorporeal blood circulation. This in turn requires the execution of arm vessel surgery known as arteriovenous fistula. Currently these procedures are done relying almost exclusively on the surgeon experience. Even with skilled surgeons, however, a high percentage of patients experience complications that require reoperation.

The ARCH system makes possible to plan such surgery in advance on the basis of patient’s data, and obtain a prediction of the vascular access function outcome, allowing an optimisation of the surgical procedure and a reduction of associated complications such as non-maturation.

A prospective study is running coordinated by the Mario Negri Institute in Italy. Preliminary results on 63 patients confirm the efficacy of this technology.

Bode A, Caroli A, Huberts W, Planken N, Antiga L, Bosboom M, Remuzzi A, Tordoir J. Clinical study protocol for the ARCH project - computational modeling for improvement of outcome after vascular access creation. J Vasc Access. 2011 Oct-Dec;12(4):369-76. doi: 10.5301/JVA.2011.8382.
Caroli A, Manini S, Antiga L, Passera K, Ene-Iordache B, Rota S, Remuzzi G, Bode A, Leermakers J, van de Vosse FN, Vanholder R, Malovrh M, Tordoir J, Remuzzi A. Validation of a patient-specific hemodynamic computational model for surgical planning of vascular access in hemodialysis patients. Kidney Int. 2013 Dec;84(6):1237-45. doi: 10.1038/ki.2013.188.
Public dissemination: Euronews coverage target also ARCH project http://www.euronews.com/2012/02/14/picture-my-body/

IMAGE GALLERY:

NEWS

News Avicenna Alliance at RAPS meeting in Pittsburgh

Avicenna Alliance at RAPS meeting in Pittsburgh

On October 8th, various key members of the Avicenna Alliance including Marc Horner, International Affairs WG leader, Martha de Cuhna, Policy Development WG Leader, and our new partner Surash Surash from the leading Notified Body TüV SüD, spoke at the Regulatory Affairs Professional Society (RAPS) meeting in Pittsburgh to highlight the essential and increasing role of in silico methods throughout the total product life cycle of medical devices.

News Avicenna Alliance Welcomes the Notified Body TÜV SÜD as a New Partner

Avicenna Alliance Welcomes the Notified Body TÜV SÜD as a New Partner

The Avicenna Alliance is delighted to welcome TÜV SÜD as its newest Partner. TÜV SÜD is a leading Notified Body operating across multiple regulatory territories, including the EU, the United States, the UK, and Asia. With more than 150 years of experience, a presence in 1,000 locations worldwide, and over 30,000 employees, TÜV SÜD is a trusted global partner in testing, inspection, certification, and training solutions.

News The Alliance at the iSi Health Symposium

The Alliance at the iSi Health Symposium

On 11 and 12 September 2025, our partner iSi Health, Erica Beaucage-Gauvreau and Rocio Castro Vinuelas, organised an excellent symposium in Leuven to bring together key players in the in silico community and promote networking, brainstorming and exchanges.

Sign up for our monthly newsletter!

Sign up for our monthly newsletter!

Fill in the fields you find below

Avicenna Alliance is an initiative of:

Avicenna VPH

© 2018-2025 Avicenna Alliance | powered by We Berry